Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Heart Failure
Search: search_blue_button Advanced Search
Circulation: Heart Failure. 2009;2:253-261
doi: 10.1161/CIRCHEARTFAILURE.108.817346
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hershberger, R. E.
Right arrow Articles by Siegfried, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hershberger, R. E.
Right arrow Articles by Siegfried, J. D.
Related Collections
Right arrow Clinical genetics
Right arrow Other heart failure
Right arrow Myocardial cardiomyopathy disease
Right arrow Other diagnostic testing

Advances in Heart Failure

Progress With Genetic Cardiomyopathies

Screening, Counseling, and Testing in Dilated, Hypertrophic, and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Ray E. Hershberger, MD; Jason Cowan, MS; Ana Morales, MS, CGC and Jill D. Siegfried, MS, CGC

From the Cardiovascular Division, University of Miami Miller School of Medicine, Miami, Fla.

Correspondence to Ray E. Hershberger, MD, Cardiovascular Division, Clinical Research Building, C-205, University of Miami Miller School of Medicine, 1120 NW 14th Str., Miami, FL 33136. E-mail rhershberger{at}med.miami.edu

This review focuses on the genetic cardiomyopathies: principally dilated cardiomyopathy, with salient features of hypertrophic cardiomyopathy and arrhythmogenic right ventricular dysplasia/cardiomyopathy, regarding genetic etiology, genetic testing, and genetic counseling. Enormous progress has recently been made in identifying genetic causes for each cardiomyopathy, and key phenotype and genotype information is reviewed. Clinical genetic testing is rapidly emerging with a principal rationale of identifying at-risk asymptomatic or disease-free relatives. Knowledge of a disease-causing mutation can guide clinical surveillance for disease onset, thereby enhancing preventive and treatment interventions. Genetic counseling is also indicated for patients and their family members regarding the symptoms of their cardiomyopathy, its inheritance pattern, family screening recommendations, and genetic testing options and possible results.

Key Words: arrhythmia • cardiomyopathy • genetics • genetic counseling • genetic testing